There were 2,217 press releases posted in the last 24 hours and 440,080 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
联拓生物在2023年欧洲肿瘤内科学会年会(ESMO)上公布了Infigratinib治疗胃癌患者的IIa期研究数据

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image